Cargando…
Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature
At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first...
Autores principales: | Bloise, Silvia, Marcellino, Alessia, Martucci, Vanessa, Sanseviero, Mariateresa, Testa, Alessia, Del Giudice, Emanuela, Spatuzzo, Mattia, Sermoneta, Daniel, Ventriglia, Flavia, Lubrano, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321070/ https://www.ncbi.nlm.nih.gov/pubmed/35883977 http://dx.doi.org/10.3390/children9070993 |
Ejemplares similares
-
Emergency Department Admissions of Children with Chest Pain before and during COVID-19 Pandemic
por: Lubrano, Riccardo, et al.
Publicado: (2023) -
Point-of-Care Thoracic Ultrasound in Children: New Advances in Pediatric Emergency Setting
por: Bloise, Silvia, et al.
Publicado: (2023) -
Cross-Sectional Survey on BNT162b2 mRNA COVID-19 Vaccine Serious Adverse Events in Children 5 to 11 Years of Age: A Monocentric Experience
por: Bloise, Silvia, et al.
Publicado: (2022) -
Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults
por: Bloise, Silvia, et al.
Publicado: (2021) -
Lung ultrasound in children drowning victims in pediatric emergency department
por: Bloise, Silvia, et al.
Publicado: (2022)